Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses
Abstract
Innate defense regulator RP-182 targets CD206 high M2-like macrophages in malignant and noncancerous diseases.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 12, 2020
- Source ID
- 10.1126/scitranslmed.aax6337
Entities
People
- Abisola Abisoye-Ogunniyan
- Ahmad Bin Salam
- Amber E. de Groot
- Anghesom Ghebremedhin
- Anju Singh
- Anton Simeonov
- Balasubramanyam Karanam
- Bolormaa Baljinnyam
- Chan-young Ock
- Clayton Yates
- Dandan Li
- Henry Lopez
- Jason C White
- Jelani C. Zarif
- Jesse M Jaynes
- Juan Jose Marugan
- Keyur Talsania
- Lixin Fan
- Marc Ferrer
- Michael Ronzetti
- Mones Abu-Asab
- Monika Mehta
- Myagmarjav Dashnyam
- Natalia de Val
- Nathan Pate
- Noel Southall
- Parimal Kumar
- Raul Calvo
- Ruksana Amin
- Sarangan Ravichandran
- Serguei Kozlov
- Taivan Odzorig
- Taylor Aiken
- Theresa Guerin
- Udo Rudloff
- Vicky Chen
- Victoria Nguyen
- Wendy Bautista
- Xin Hu
- Yansong Bian
- Yongmei Zhao
- Zachary Knotts
Organizations
- Frederick National Laboratory for Cancer Research
- Johns Hopkins School of Medicine
- Johns Hopkins University
- National Cancer Institute
- National Center for Advancing Translational Sciences
- National Eye Institute
- National Institute on Minority Health and Health Disparities
- National Institutes of Health
- Tuskegee University
- United States Department of Defense
- University of Wisconsin–Madison